Adapting the Goal Attainment Approach for Major Depressive Disorder Maggie McCueSagar V. ParikhClément François Commentary Open access 21 August 2019 Pages: 167 - 176
Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk? Victor M. Rivera Commentary Open access 16 July 2019 Pages: 177 - 184
Two Sides to Every Story: Perspectives from Four Patients and a Healthcare Professional on Multiple Sclerosis Disease Progression Jeri BurtchellKristen FettyDaniel Kantor Commentary Open access 04 July 2019 Pages: 185 - 205
Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America Judith SteinbergYara D. FragosoAdriana Carrá Commentary Open access 24 May 2019 Pages: 207 - 214
Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia Afzal JavedHolger ArthurSofia Pappa Commentary Open access 16 May 2019 Pages: 215 - 230
Fingolimod Immune Effects Beyond Its Sequestration Ability Francesco SicaDiego CentonzeFabio Buttari Review Open access 06 November 2019 Pages: 231 - 240
Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations Brian BarryApril A. ErwinCarlo Tornatore Review Open access 01 November 2019 Pages: 241 - 250
Cognitive Fatigability Interventions in Neurological Conditions: A Systematic Review Lisa A. S. WalkerAlyssa P. Lindsay-BrownJason A. Berard Review Open access 04 October 2019 Pages: 251 - 271
Therapy of Sialorrhea with Botulinum Neurotoxin Wolfgang H. JostTobias BäumerGanesh Bavikatte Review Open access 21 September 2019 Pages: 273 - 288
Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review Amir Abbas Tahami MonfaredGenevieve MeierDarren Joe Review Open access 12 September 2019 Pages: 289 - 305
Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer Jeremy K. Cutsforth-GregoryPhillip A. Low Review Open access 27 August 2019 Pages: 307 - 324
Diagnosing and Treating Depression in Patients with Alzheimer’s Disease Anna D. BurkeDanielle GoldfarbSehar Khokher Review Open access 21 August 2019 Pages: 325 - 350
Deep Learning and Neurology: A Systematic Review Aly Al-Amyn VallianiDaniel RantiEric Karl Oermann Review Open access 21 August 2019 Pages: 351 - 365
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study) Annette F. OkaiLilyana Amezcuathe CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators Original Research Open access 25 October 2019 Pages: 367 - 381
Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population Tara NazarethManasi DatarTzy-Chyi Yu Original Research Open access 28 September 2019 Pages: 383 - 395
Long-Term Observation of the Safety and Effectiveness of Enzyme Replacement Therapy in Japanese Patients with Pompe Disease: Results From the Post-marketing Surveillance Hitoshi NaguraJiro HokugoKazuo Ueda Original Research Open access 26 September 2019 Pages: 397 - 409
Effect of Anodal tDCS on Articulatory Accuracy, Word Production, and Syllable Repetition in Subjects with Aphasia: A Crossover, Double-Blinded, Sham-Controlled Trial Camila Vila-NovaPedro H. LucenaFernanda Q. Campbell Original Research Open access 20 August 2019 Pages: 411 - 424
Can Generic Intravenous Levetiracetam Be Used for Acute Repetitive Convulsive Seizure or Status Epilepticus? A Randomized Controlled Trial Rachot WongjirattikarnKittisak SawanyawisuthSomsak Tiamkao Original Research Open access 12 August 2019 Pages: 425 - 431
Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital Yusuke NakamuraIsao ShibataJörg Mahlich Original Research Open access 10 August 2019 Pages: 433 - 447
Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies Tina deVriesAngela DentisteDavid Jacobs Original Research Open access 01 August 2019 Pages: 449 - 460
Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials Angelo GhezziTanuja ChitnisDaniela Pohl Original Research Open access 19 July 2019 Pages: 461 - 475
Late Onset of Neuromyelitis Optica Spectrum Disorders Yara Dadalti FragosoHeloisa Helena RuoccoGutemberg Augusto C. Santos Original Research Open access 02 July 2019 Pages: 477 - 482
A Novel Dual-Frequency Deep Brain Stimulation Paradigm for Parkinson’s Disease Jessica A. KarlBichun OuyangLeo Verhagen Metman Original Research Open access 26 June 2019 Pages: 483 - 489
Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study Charlotte LawthomPedro BermejoVicente Villanueva Original Research Open access 16 May 2019 Pages: 491 - 504
Case Report of a Novel Technique for Repair of the Vertebral Artery During Cranial Surgery Manjunath PrasadNitin Mukerji Case Report Open access 05 July 2019 Pages: 505 - 509
Correction to: Abstracts from the 5th International Porto Congress of Multiple Sclerosis Maria José Sá Correction Open access 04 November 2019 Pages: 511 - 511
Acknowledgement to Authors, Referees and Readers 2019 Marwan SabbaghAntonio Bertolotto Acknowledgement Open access 07 November 2019 Pages: 513 - 515
